---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003741"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-04-11T23:59:59+00:00"
generated_at: "2026-05-23T16:11:50.216756+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PAVmed subsidiary Lucid Diagnostics closes 14.4M share offering raising ~$16.1M net

## Summary
- Lucid Diagnostics closed sale of 14,375,000 shares at $1.20 each, including full exercise of underwriters' option.
- Net proceeds expected to be approximately $16.1 million after underwriting discounts and expenses.
- Proceeds will be used for working capital and general corporate purposes.
- Offering was made under Lucid's existing shelf registration statement (Form S-3) and prospectus supplement dated April 9, 2025.

## SEC filing metadata
- accession: 0001641172-25-003741
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000164117225003741/0001641172-25-003741-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000164117225003741/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003741
- JSON: https://secwatch.observer/filing/0001641172-25-003741.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003741.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.